CALM Cal-Maine Foods Inc.

Cal-Maine Foods Reports Third Quarter Fiscal 2018 Results

Cal-Maine Foods, Inc. (NASDAQ: CALM) today reported results for the third quarter and thirty-nine weeks ended March 3, 2018.

Net sales for the third quarter of fiscal 2018 were $435.8 million, a 42.2 percent increase, compared to $306.5 million for the third quarter of fiscal 2018. The Company reported net income of $96.3 million, or $1.99 per basic and diluted share, for the third quarter of fiscal 2018, compared to $4.1 million, or $0.09 per basic and diluted share, for the third quarter of fiscal 2017. Results for the third quarter of fiscal 2018 were favorably affected by a $35.0 million, or $0.72 per basic and diluted share, discrete tax benefit related to the Tax Cuts and Jobs Act (TCJA) tax reform legislation enacted during the period, and the subsequent revaluation of the Company’s deferred tax liabilities at the new, lower corporate tax rate.

For the thirty-nine weeks ended March 3, 2018, net sales were $1,059.8 million compared with $799.9 million for the prior-year period. The Company reported net income of $54.2 million, or $1.12 per basic and diluted share, for the thirty-nine weeks ended March 3, 2018, compared with a net loss of $49.8 million, or $1.03 per basic and diluted share, for the year-earlier period. Results for the thirty-nine week period of fiscal 2018 were favorably affected by the TCJA tax reform legislation noted above. These results also include an after-tax charge of $54.8 million, or $1.13 per basic and diluted share, as calculated using the new blended corporate tax rate for the Company's fiscal 2018. This charge was recorded in the second quarter of fiscal 2018, and was related to the settlement of previously disclosed antitrust claims that several large direct action purchasers had asserted against the Company.

Dolph Baker, chairman and chief executive officer of Cal-Maine Foods, Inc., stated, “We are pleased to report very strong financial and operating results for the third quarter of fiscal 2018, as we capitalized on improved market conditions compared with the third quarter last year. Our sales were up 42.2 percent from a year ago, reflecting strong consumer demand trends, continued grocery store promotions for shell eggs, and more moderate production growth. Together, these factors have supported higher market prices. We continued to execute our growth strategy in this favorable market environment, resulting in a significant improvement in profitability compared with the prior-year period.

“Market prices for shell eggs have continued to trend higher this fiscal year with our average customer selling prices up 36.7 percent over the third quarter last year. Market prices for non-specialty eggs have been especially strong and were up 66.6 percent compared with the prior-year period. Prices remained high through the peak holiday selling season and have continued to move up since the end of the quarter. Reports from IRI, a consumer market research firm, indicate retail demand has been very good through this same period. We also benefitted from higher egg exports compared with the same time last year. While production has moderated, the laying hen flock size has moved up modestly compared with prior-year levels, resulting in an improved balance of supply and demand. Recent USDA reports, however, show an increase in chicks hatched, which could indicate future increases in supply.

“Our specialty egg business remains a primary focus of our growth strategy as we continue to see favorable consumer demand trends. For the third quarter of fiscal 2018, specialty eggs, excluding co-pack sales, accounted for 24.3 percent of our total sales volume, compared with 23.6 percent for the same period a year ago. Specialty egg revenue was 30.2 percent of total shell egg revenue, compared with 40.8 percent for the third quarter of fiscal 2017, as a result of significantly higher market prices for non-specialty eggs in the current period.

“We are also focused on aligning our future production capacity with the anticipated industry-wide change in product demand, as our largest customers have made public commitments to exclusively offer cage-free eggs by future specified dates. Our primary objective is to ensure we are ready to meet our customers’ needs through this transition period, and we are prepared to make the necessary investments in our operations. As always, Cal-Maine Foods provides a diverse product mix that includes cage-free eggs, as well as other healthy and affordable options for consumers including conventional, nutritionally enhanced and organic eggs.”

Baker added, “Our operations ran well during the third quarter, as we continued to focus on efficient and responsible management across all of Cal-Maine Foods’ locations. Operating income for the third quarter was $76.2 million, compared with an operating loss of $5.2 million a year ago. Farm production costs per dozen were up slightly compared with the prior-year period. For the third quarter of fiscal 2018, our feed costs per dozen produced were consistent with the same costs incurred a year ago. Based on 2017 harvested crops, we expect to have an ample supply of our primary feed ingredients for the balance of the fiscal year.”

Pursuant to Cal-Maine Foods’ variable dividend policy, for each quarter for which the Company reports net income, the Company pays a cash dividend to shareholders in an amount equal to one-third of such quarterly income. Following a quarter for which the Company does not report net income, the Company will not pay a dividend with respect to that quarter or for a subsequent profitable quarter until the Company is profitable on a cumulative basis computed from the date of the last quarter for which a dividend was paid. Therefore, the Company did not pay a dividend with respect to the fourth quarter of fiscal 2016, or any quarter of fiscal 2017, and will not pay a dividend for the first, second, or third quarters of fiscal 2018. At March 3, 2018, cumulative losses that must be recovered prior to paying a dividend were $20.5 million.

Selected operating statistics for the third quarter and year-to-date period of fiscal 2018 compared with the prior-year period are shown below:

       
  13 Weeks Ended   39 Weeks Ended
 

March 3,

2018

   

February 25,

2017

 

March 3,

2018

   

February 25,

2017

Dozen Eggs Sold (000) 273,209 263,613 785,758 758,114
Dozen Eggs Produced (000) 221,119 222,492 657,577 633,246
% Specialty Sales (dozen)* 24.3 % 23.6 % 22.9 % 23.0 %
% Specialty Sales (dollars)* 30.2 % 40.8 % 33.3 % 44.1 %
Net Average Selling Price (dozen) $ 1.545 $ 1.130 $ 1.303 $ 1.020
Net Average Selling Price Specialty Eggs (dozen)* $ 1.933 $ 1.965 $ 1.907 $ 1.980
Feed Cost (dozen) $ 0.396 $ 0.396 $ 0.387 $ 0.406
 

*Excludes co-pack specialty eggs

 

Cal-Maine Foods, Inc. is primarily engaged in the production, grading, packing and sale of fresh shell eggs, including conventional, cage-free, organic and nutritionally-enhanced eggs. The Company, which is headquartered in Jackson, Mississippi, is the largest producer and distributor of fresh shell eggs in the United States and sells the majority of its shell eggs in states across the southwestern, southeastern, mid-western and mid-Atlantic regions of the United States.

Statements contained in this press release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements are based on management’s current intent, belief, expectations, estimates and projections regarding our company and our industry. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions and other factors that are difficult to predict and may be beyond our control. The factors that could cause actual results to differ materially from those projected in the forward-looking statements include, among others, (i) the risk factors set forth in the Company’s SEC filings (including its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K), (ii) the risks and hazards inherent in the shell egg business (including disease, pests, weather conditions and potential for recall), (iii) changes in the demand for and market prices of shell eggs and feed costs, (iv) our ability to predict and meet demand for cage-free and other specialty eggs, (v) risks, changes or obligations that could result from our future acquisition of new flocks or businesses and risks or changes that may cause conditions to completing a pending acquisition not to be met, and (vi) adverse results in pending litigation matters. In addition, the Company continues to assess the impact of the recently enacted federal tax reform legislation on its business and consolidated financial statements. SEC filings may be obtained from the SEC or the Company’s website, www.calmainefoods.com. Readers are cautioned not to place undue reliance on forward-looking statements because, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. Further, the forward-looking statements included herein are only made as of the respective dates thereof, or if no date is stated, as of the date hereof. Except as otherwise required by law, we disclaim any intent or obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise.

       
CAL-MAINE FOODS, INC. AND SUBSIDIARIES
FINANCIAL HIGHLIGHTS

(Unaudited)

(In thousands, except per share amounts)

 
SUMMARY STATEMENTS OF OPERATIONS
 
13 Weeks Ended 39 Weeks Ended

 

March 3,

2018

   

February 25,

2017

March 3,

2018

   

February 25,

2017

Net sales $ 435,820 $ 306,540 $ 1,059,837 $ 799,929
Cost of sales 315,722   267,375   840,007   766,385  
Gross profit 120,098 39,165 219,830 33,544
Selling, general, and administrative expense 44,175 43,738 128,045 125,985
Legal settlement expense 80,750
(Gain) Loss on disposal of fixed assets (279 ) 622   (325 ) 1,361  
Operating income (loss) 76,202 (5,195 ) 11,360 (93,802 )
Other income, net 11,855   9,360   12,087   12,659  
Income (loss) before income taxes and noncontrolling interest 88,057 4,165 23,447 (81,143 )
Income tax (benefit) expense (8,301 ) 34   (30,653 ) (31,327 )
Net income (loss) before noncontrolling interest 96,358 4,131 54,100 (49,816 )
Less: Net income (loss) attributable to noncontrolling interest 64   (8 ) (65 ) (9 )
Net income (loss) attributable to Cal-Maine Foods, Inc. $ 96,294   $ 4,139   $ 54,165   $ (49,807 )
 
Net income (loss) per share:
Basic $ 1.99   $ 0.09   $ 1.12   $ (1.03 )
Diluted $ 1.99   $ 0.09   $ 1.12   $ (1.03 )
Weighted average shares outstanding
Basic 48,361 48,286 48,340 48,285
Diluted 48,476 48,417 48,460 48,285
       
CAL-MAINE FOODS, INC. AND SUBSIDIARIES
FINANCIAL HIGHLIGHTS

(Unaudited)

(In thousands)

 
SUMMARY BALANCE SHEETS
 
March 3, 2018 June 3, 2017
ASSETS
Cash and short-term investments $ 283,448 $ 156,026
Receivables 121,642 64,509
Income tax receivable 52,691
Inventories 165,363 160,692
Prepaid expenses and other current assets 2,074 2,288
Current assets 572,527 436,206
 
Property, plant and equipment (net) 433,482 458,184
Other noncurrent assets 137,674 138,704
Total assets $ 1,143,683   $ 1,033,094
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable and accrued expenses $ 96,071 $ 59,853
Accrued legal settlement expense 80,750
Current maturities of long-term debt and capital lease obligations 3,926 4,826
Current liabilities 180,747 64,679
 
Long-term debt and capital lease obligations, less current maturities 3,351 6,113
Deferred income taxes and other liabilities 59,926 117,809
Stockholders' equity 899,659 844,493
Total liabilities and stockholders' equity $ 1,143,683   $ 1,033,094

EN
02/04/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cal-Maine Foods Inc.

Cal-Maine Foods Inc: 1 director

A director at Cal-Maine Foods Inc sold 1,287,616 shares at 90.600USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

SHAK SHAKE SHACK INC. CLASS A
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OCUL OCULAR THERAPEUTIX
HNRG HALLADOR ENERGY CO.
EAT BRINKER INTERNATIONAL INC.
DECK DECKERS OUTDOOR CORPORATION
CSIQ CANADIAN SOLAR INC.
COLL COLLEGIUM PHARMACEUTICAL INC.
CALM CAL-MAINE FOODS INC.
CAKE CHEESECAKE FACTORY INCORPORATED
BBW BUILD-A-BEAR WORKSHOP
ASPN ASPEN AEROGELS
APOG APOGEE ENTERPRISES INC.
AMSC AMERICAN SUPERCONDUCTOR CORP.
ALB ALBEMARLE CORPORATION
AAOI APPLIED OPTOELECTRONICS INC.
COF CAPITAL ONE FINANCIAL CORPORATION
ZUMZ ZUMIEZ INC.
VFC V.F. CORPORATION
CRVS CORVUS PHARMACEUTICALS
DESP DESPEGAR.COM CORP.
FNKO FUNKO CLASS A
AMD ADVANCED MICRO DEVICES INC.
ACMR ACM RESEARCH
PPIH PERMA PIPE INTERNATIONAL HOLDINGS
GLOB GAZIT-GLOBE LTD.
PLMR PALOMAR HOLDINGS
CAPR CAPRICOR THERAPEUTICS
CRMD CORMEDIX INC.
BILL BILL.COM HOLDINGS
ADPT ADAPTIVE BIOTECHNOLOGIES
GII SPDR S&P GLOBAL INFRASTRUCTURE
TVTX TRAVERE THERAPEUTICS INC
VHI VALHI INC.
ALKT ALKAMI TECHNOLOGY INC
SOFI SOFI TECHNOLOGIES INC
EVGO EVGO INC
ENVX ENOVIX CORP
TSE TRINSEO PLC
ASTS AST SPACEMOBILE INC
PLL PIEDMONT LITHIUM INC
MLTX MOONLAKE IMMUNOTHERAPEUTICS
EWTX EDGEWISE THERAPEUTICS INC
FTAI FORTRESS TRANSN & INFRAS INVS LLC
RDW REDWIRE CORP
COYA COYA THERAPEUTICS INC
SKWD SKYWARD SPECIALTY INS GROUP INC
MLYS MINERALYS THERAPEUTICS INC
ELVN IMARA INC
WGS GENEDX HOLDINGS CORP.
KGS KODIAK GAS SERVICES INC
BYRN BYRNA TECHNOLOGIES INC
NMRA NEUMORA THERAPEUTICS INC
ATGL ALPHA TECHNOLOGY GROUP LTD
NGNE NEUROGENE INC
DAVE DAVE INC
LENZ LENZ THERAPEUTICS INC
IBTA IBOTTA INC
FIP FTAI INFRASTRUCTURE INC
CLMT CALUMET INC
NUTX NUTEX HEALTH INC
DOGZ DOGNESS INTERNATIONAL CORP
TECX TD GLOBAL TECHNOLOGY LEADERS CAD HEDGED INDEX ETF
TBNK TD CANADIAN BANK DIVIDEND INDEX ETF
RDDT REDDIT INC
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Panic Selling Achieved, Now Waiting for Panic Buying For the past two weeks we have noted that a test of the lows, and possibly a break to new lows, is increasingly likely on the S&P 500, Nasdaq 100 (QQQ), and Russell 2000 (IWM). We are getting that test now, following some indiscriminate selling late last week which produced back-to-back 80%+ downside volume days on the NYSE. There can certainly be more 80%-90%+ downside days that take the indexes to new lows, but we will need to see back-to-b...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch